| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 124 | 2024 | 2472 | 20.290 |
Why?
|
| Hypogonadism | 47 | 2021 | 798 | 7.400 |
Why?
|
| Hormone Replacement Therapy | 38 | 2024 | 750 | 6.580 |
Why?
|
| Androgens | 35 | 2024 | 1285 | 5.750 |
Why?
|
| Prostatic Neoplasms | 68 | 2021 | 11106 | 3.950 |
Why?
|
| Erectile Dysfunction | 25 | 2017 | 444 | 3.470 |
Why?
|
| Prostate-Specific Antigen | 23 | 2019 | 2465 | 2.130 |
Why?
|
| Andropause | 4 | 2014 | 8 | 1.870 |
Why?
|
| 5-alpha Reductase Inhibitors | 4 | 2018 | 112 | 1.730 |
Why?
|
| Testis | 9 | 2024 | 792 | 1.580 |
Why?
|
| Sexual Dysfunction, Physiological | 5 | 2019 | 361 | 1.330 |
Why?
|
| Azasteroids | 3 | 2014 | 37 | 1.150 |
Why?
|
| Sexual Dysfunctions, Psychological | 5 | 2021 | 192 | 1.000 |
Why?
|
| Orchiectomy | 6 | 2024 | 463 | 1.000 |
Why?
|
| Finasteride | 2 | 2018 | 86 | 0.990 |
Why?
|
| Penile Prosthesis | 9 | 2007 | 32 | 0.980 |
Why?
|
| Prostate | 12 | 2014 | 1773 | 0.970 |
Why?
|
| Male | 179 | 2024 | 360358 | 0.960 |
Why?
|
| Infertility, Male | 5 | 2013 | 396 | 0.900 |
Why?
|
| Prostatectomy | 11 | 2019 | 1824 | 0.840 |
Why?
|
| Lizards | 3 | 2021 | 50 | 0.840 |
Why?
|
| Radioimmunoassay | 3 | 2013 | 861 | 0.810 |
Why?
|
| Spermatogenesis | 6 | 2008 | 258 | 0.800 |
Why?
|
| Estrogens | 3 | 2013 | 1521 | 0.730 |
Why?
|
| Deficiency Diseases | 4 | 2017 | 74 | 0.730 |
Why?
|
| Urology | 3 | 2019 | 400 | 0.730 |
Why?
|
| Cardiovascular System | 3 | 2019 | 834 | 0.710 |
Why?
|
| Libido | 7 | 2021 | 124 | 0.700 |
Why?
|
| Men's Health | 2 | 2017 | 73 | 0.680 |
Why?
|
| Myocardial Infarction | 7 | 2015 | 11459 | 0.660 |
Why?
|
| Dihydrotestosterone | 5 | 2014 | 195 | 0.650 |
Why?
|
| Luteinizing Hormone | 3 | 2019 | 820 | 0.640 |
Why?
|
| Eunuchism | 1 | 2018 | 19 | 0.630 |
Why?
|
| Cardiovascular Diseases | 15 | 2024 | 15498 | 0.610 |
Why?
|
| Humans | 173 | 2024 | 760617 | 0.600 |
Why?
|
| Penile Erection | 8 | 2017 | 101 | 0.600 |
Why?
|
| Nerve Growth Factor | 1 | 2018 | 158 | 0.570 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2017 | 550 | 0.570 |
Why?
|
| Prostatic Hyperplasia | 5 | 2019 | 521 | 0.570 |
Why?
|
| Andrology | 1 | 2017 | 11 | 0.570 |
Why?
|
| Hysteria | 1 | 2016 | 20 | 0.560 |
Why?
|
| Prescription Drugs | 2 | 2014 | 631 | 0.550 |
Why?
|
| Spermatozoa | 6 | 2008 | 629 | 0.510 |
Why?
|
| Stroke | 5 | 2014 | 9712 | 0.480 |
Why?
|
| Sexuality | 2 | 2017 | 180 | 0.470 |
Why?
|
| Testosterone Congeners | 2 | 2019 | 62 | 0.470 |
Why?
|
| Nitriles | 2 | 2013 | 971 | 0.460 |
Why?
|
| Triazoles | 2 | 2013 | 903 | 0.450 |
Why?
|
| Aromatase Inhibitors | 3 | 2013 | 513 | 0.450 |
Why?
|
| Dialysis | 1 | 2013 | 73 | 0.450 |
Why?
|
| Mass Media | 1 | 2016 | 302 | 0.450 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2012 | 410 | 0.450 |
Why?
|
| Clomiphene | 1 | 2013 | 71 | 0.440 |
Why?
|
| Sexual Behavior | 6 | 2024 | 2187 | 0.440 |
Why?
|
| Androstenedione | 1 | 2013 | 131 | 0.430 |
Why?
|
| Estrogen Antagonists | 1 | 2013 | 150 | 0.430 |
Why?
|
| Cryptorchidism | 5 | 2002 | 151 | 0.420 |
Why?
|
| Phosphodiesterase Inhibitors | 4 | 2007 | 214 | 0.410 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.410 |
Why?
|
| Periodicals as Topic | 2 | 2016 | 1463 | 0.410 |
Why?
|
| Penis | 3 | 2014 | 210 | 0.400 |
Why?
|
| Receptors, Androgen | 3 | 2014 | 1079 | 0.400 |
Why?
|
| Oligospermia | 3 | 2006 | 59 | 0.390 |
Why?
|
| Practice Guidelines as Topic | 11 | 2017 | 7389 | 0.390 |
Why?
|
| Watchful Waiting | 1 | 2016 | 491 | 0.380 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2002 | 2917 | 0.380 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 1148 | 0.380 |
Why?
|
| Disease Progression | 9 | 2017 | 13495 | 0.370 |
Why?
|
| Epididymis | 3 | 1998 | 227 | 0.370 |
Why?
|
| Middle Aged | 61 | 2019 | 220584 | 0.360 |
Why?
|
| Acid Phosphatase | 1 | 2010 | 139 | 0.340 |
Why?
|
| Computers, Analog | 1 | 2009 | 6 | 0.340 |
Why?
|
| Androgen-Binding Protein | 1 | 2009 | 10 | 0.340 |
Why?
|
| Transsexualism | 1 | 2013 | 208 | 0.340 |
Why?
|
| Circadian Rhythm | 2 | 2019 | 2569 | 0.330 |
Why?
|
| Penile Induration | 1 | 2009 | 16 | 0.330 |
Why?
|
| Aged | 49 | 2021 | 169042 | 0.310 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 1438 | 0.300 |
Why?
|
| Vas Deferens | 2 | 1998 | 54 | 0.290 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2007 | 21 | 0.290 |
Why?
|
| Risk Factors | 25 | 2024 | 74115 | 0.290 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 860 | 0.270 |
Why?
|
| Brachytherapy | 1 | 2014 | 1223 | 0.270 |
Why?
|
| Spermatic Cord | 1 | 2006 | 23 | 0.270 |
Why?
|
| Bibliometrics | 1 | 2009 | 352 | 0.260 |
Why?
|
| Varicocele | 1 | 2006 | 75 | 0.260 |
Why?
|
| Kallikreins | 2 | 2017 | 220 | 0.250 |
Why?
|
| Orgasm | 3 | 2017 | 63 | 0.250 |
Why?
|
| Penile Diseases | 2 | 1996 | 44 | 0.250 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 161 | 0.240 |
Why?
|
| Adult | 42 | 2019 | 220969 | 0.240 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 973 | 0.230 |
Why?
|
| Science | 1 | 2007 | 239 | 0.230 |
Why?
|
| Carbolines | 1 | 2006 | 295 | 0.230 |
Why?
|
| Organ Size | 6 | 2014 | 2252 | 0.230 |
Why?
|
| History, 20th Century | 4 | 2018 | 2764 | 0.230 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 1520 | 0.220 |
Why?
|
| Apoptosis | 5 | 2002 | 9476 | 0.220 |
Why?
|
| Population Surveillance | 1 | 2014 | 2595 | 0.220 |
Why?
|
| Germ Cells | 2 | 1998 | 634 | 0.220 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2003 | 81 | 0.220 |
Why?
|
| Gynecomastia | 1 | 2004 | 86 | 0.220 |
Why?
|
| Culture | 1 | 2007 | 623 | 0.210 |
Why?
|
| Laboratories | 1 | 2006 | 458 | 0.210 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 241 | 0.210 |
Why?
|
| Prejudice | 1 | 2007 | 571 | 0.210 |
Why?
|
| Dehydroepiandrosterone | 1 | 2003 | 258 | 0.200 |
Why?
|
| Aging | 4 | 2021 | 8699 | 0.200 |
Why?
|
| Pituitary Diseases | 1 | 2003 | 135 | 0.200 |
Why?
|
| Body Composition | 1 | 2011 | 2426 | 0.200 |
Why?
|
| Retrospective Studies | 22 | 2017 | 80566 | 0.190 |
Why?
|
| Testicular Neoplasms | 3 | 1994 | 800 | 0.190 |
Why?
|
| Prolactin | 1 | 2003 | 625 | 0.190 |
Why?
|
| Societies, Medical | 3 | 2024 | 3900 | 0.190 |
Why?
|
| Chromosome Deletion | 1 | 2006 | 1386 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2016 | 3426 | 0.180 |
Why?
|
| Clinical Trials as Topic | 5 | 2019 | 7995 | 0.180 |
Why?
|
| Biological Assay | 2 | 2018 | 626 | 0.180 |
Why?
|
| Endocrinology | 1 | 2007 | 442 | 0.180 |
Why?
|
| Pituitary Gland | 1 | 2003 | 635 | 0.180 |
Why?
|
| Gels | 2 | 2014 | 420 | 0.180 |
Why?
|
| Bone Density | 1 | 2013 | 3548 | 0.180 |
Why?
|
| Seminal Vesicles | 2 | 1997 | 103 | 0.170 |
Why?
|
| Palliative Care | 2 | 2005 | 3592 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2010 | 2688 | 0.160 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 3451 | 0.160 |
Why?
|
| Risk | 4 | 2016 | 9604 | 0.160 |
Why?
|
| Lithotripsy | 2 | 1990 | 140 | 0.160 |
Why?
|
| Age Factors | 6 | 2017 | 18381 | 0.160 |
Why?
|
| Diverticulum | 2 | 1997 | 137 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2018 | 1565 | 0.150 |
Why?
|
| Body Temperature | 2 | 1999 | 780 | 0.150 |
Why?
|
| Mass Screening | 4 | 2010 | 5424 | 0.150 |
Why?
|
| Biopsy | 5 | 2009 | 6762 | 0.150 |
Why?
|
| China | 1 | 2024 | 2374 | 0.150 |
Why?
|
| Animals | 20 | 2024 | 168201 | 0.150 |
Why?
|
| Calcinosis | 1 | 2006 | 1469 | 0.140 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2527 | 0.140 |
Why?
|
| Teratoma | 2 | 1992 | 404 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 2921 | 0.140 |
Why?
|
| United States | 13 | 2018 | 72272 | 0.140 |
Why?
|
| Postoperative Complications | 6 | 2017 | 15612 | 0.140 |
Why?
|
| Prosthesis Failure | 2 | 2001 | 1204 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 9277 | 0.140 |
Why?
|
| Reproductive Techniques | 1 | 1996 | 41 | 0.130 |
Why?
|
| Gonadotropins | 1 | 1997 | 241 | 0.130 |
Why?
|
| Reference Values | 2 | 2017 | 4919 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2018 | 64568 | 0.130 |
Why?
|
| Ureteral Diseases | 1 | 1996 | 63 | 0.130 |
Why?
|
| Nuclear Envelope | 1 | 1997 | 162 | 0.130 |
Why?
|
| Aged, 80 and over | 12 | 2014 | 58894 | 0.130 |
Why?
|
| Journalism, Medical | 1 | 2016 | 73 | 0.130 |
Why?
|
| Statistics as Topic | 2 | 2013 | 2358 | 0.130 |
Why?
|
| Czech Republic | 1 | 2015 | 74 | 0.130 |
Why?
|
| Drug Monitoring | 3 | 2015 | 960 | 0.130 |
Why?
|
| Piperazines | 2 | 2004 | 2521 | 0.130 |
Why?
|
| Bone Diseases | 1 | 2019 | 418 | 0.130 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2016 | 167 | 0.130 |
Why?
|
| Bioethical Issues | 1 | 2016 | 120 | 0.130 |
Why?
|
| Drug Implants | 3 | 2012 | 230 | 0.130 |
Why?
|
| Mycobacterium Infections | 1 | 1996 | 122 | 0.120 |
Why?
|
| Spinal Cord Compression | 1 | 2017 | 233 | 0.120 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2018 | 488 | 0.120 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1992 | 283 | 0.120 |
Why?
|
| Mexico | 1 | 2017 | 756 | 0.120 |
Why?
|
| Europe | 1 | 2021 | 3413 | 0.120 |
Why?
|
| Time Factors | 6 | 2017 | 39913 | 0.120 |
Why?
|
| Medical Audit | 1 | 2016 | 453 | 0.120 |
Why?
|
| Risk Assessment | 6 | 2017 | 23972 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2018 | 959 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 2067 | 0.110 |
Why?
|
| Weights and Measures | 1 | 2013 | 41 | 0.110 |
Why?
|
| Hot Temperature | 2 | 1998 | 1437 | 0.110 |
Why?
|
| Heterosexuality | 1 | 2016 | 309 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4910 | 0.110 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1993 | 81 | 0.110 |
Why?
|
| Immunoassay | 1 | 2017 | 744 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6340 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3705 | 0.110 |
Why?
|
| Vasectomy | 1 | 1993 | 51 | 0.110 |
Why?
|
| United States Food and Drug Administration | 2 | 2018 | 1661 | 0.110 |
Why?
|
| Sex Reassignment Procedures | 1 | 2013 | 70 | 0.110 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 1409 | 0.100 |
Why?
|
| Dysgerminoma | 1 | 1992 | 66 | 0.100 |
Why?
|
| Prosthesis Design | 5 | 2007 | 2114 | 0.100 |
Why?
|
| Running | 1 | 1997 | 488 | 0.100 |
Why?
|
| Long-Term Care | 2 | 2010 | 631 | 0.100 |
Why?
|
| Therapeutic Irrigation | 1 | 1994 | 289 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2009 | 15828 | 0.100 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2012 | 58 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 662 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1528 | 0.100 |
Why?
|
| Canada | 1 | 2017 | 2118 | 0.100 |
Why?
|
| Temperature | 2 | 1997 | 2223 | 0.100 |
Why?
|
| Infusions, Subcutaneous | 1 | 2011 | 43 | 0.100 |
Why?
|
| Expert Testimony | 1 | 2014 | 364 | 0.100 |
Why?
|
| Hyponatremia | 1 | 1994 | 279 | 0.090 |
Why?
|
| Endometrium | 1 | 1994 | 403 | 0.090 |
Why?
|
| Sexual Partners | 1 | 2016 | 800 | 0.090 |
Why?
|
| Comorbidity | 3 | 2017 | 10505 | 0.090 |
Why?
|
| Sulfones | 2 | 2004 | 447 | 0.090 |
Why?
|
| Quality of Life | 5 | 2021 | 13347 | 0.090 |
Why?
|
| Survival Rate | 3 | 2015 | 12719 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 15251 | 0.090 |
Why?
|
| Fecal Impaction | 1 | 1990 | 32 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 39063 | 0.090 |
Why?
|
| Purines | 2 | 2004 | 606 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2014 | 12334 | 0.090 |
Why?
|
| Gender Identity | 1 | 2016 | 765 | 0.080 |
Why?
|
| Anemia | 1 | 2019 | 1504 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2013 | 503 | 0.080 |
Why?
|
| Baltimore | 1 | 2010 | 231 | 0.080 |
Why?
|
| World Health Organization | 1 | 1995 | 1321 | 0.080 |
Why?
|
| Prevalence | 5 | 2015 | 15689 | 0.080 |
Why?
|
| PubMed | 1 | 2009 | 129 | 0.080 |
Why?
|
| Ureteral Calculi | 1 | 1990 | 114 | 0.080 |
Why?
|
| Motivation | 1 | 2018 | 2003 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 1995 | 1269 | 0.080 |
Why?
|
| Journal Impact Factor | 1 | 2009 | 153 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10754 | 0.080 |
Why?
|
| Biopsy, Needle | 2 | 2008 | 1624 | 0.080 |
Why?
|
| Endocrine System Diseases | 1 | 2010 | 249 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2017 | 10199 | 0.070 |
Why?
|
| Fertilization in Vitro | 1 | 1995 | 1292 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2100 | 0.070 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 712 | 0.070 |
Why?
|
| Recurrence | 2 | 2017 | 8426 | 0.070 |
Why?
|
| Age Distribution | 2 | 2004 | 2871 | 0.070 |
Why?
|
| Young Adult | 5 | 2019 | 59179 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2014 | 1315 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2008 | 274 | 0.070 |
Why?
|
| DNA Fragmentation | 2 | 1998 | 237 | 0.070 |
Why?
|
| Injections | 1 | 2010 | 832 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2010 | 991 | 0.070 |
Why?
|
| Proteins | 2 | 1992 | 6030 | 0.070 |
Why?
|
| Chemistry, Clinical | 1 | 2006 | 64 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2189 | 0.070 |
Why?
|
| ROC Curve | 1 | 2014 | 3575 | 0.070 |
Why?
|
| Flushing | 1 | 2006 | 52 | 0.070 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 962 | 0.070 |
Why?
|
| Self Report | 1 | 2017 | 3723 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2015 | 1669 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 14591 | 0.060 |
Why?
|
| Dyspepsia | 1 | 2006 | 116 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 1988 | 458 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 1998 | 1759 | 0.060 |
Why?
|
| Dogs | 1 | 2010 | 3838 | 0.060 |
Why?
|
| Obesity | 3 | 2017 | 12933 | 0.060 |
Why?
|
| Patient Selection | 2 | 2014 | 4237 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2019 | 41457 | 0.060 |
Why?
|
| Stents | 2 | 1993 | 3178 | 0.060 |
Why?
|
| Empty Sella Syndrome | 1 | 2003 | 14 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2013 | 1604 | 0.060 |
Why?
|
| Diagnosis, Differential | 4 | 2011 | 12966 | 0.060 |
Why?
|
| Prostatic Diseases | 1 | 2004 | 57 | 0.060 |
Why?
|
| Estradiol | 3 | 2019 | 1937 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 9026 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4341 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2015 | 3954 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6474 | 0.050 |
Why?
|
| Fertility | 1 | 2008 | 769 | 0.050 |
Why?
|
| Carcinoma | 1 | 2015 | 2327 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 11116 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 3822 | 0.050 |
Why?
|
| Evidence-Based Medicine | 4 | 2017 | 3680 | 0.050 |
Why?
|
| Reference Standards | 1 | 2006 | 1002 | 0.050 |
Why?
|
| Polycythemia | 1 | 2004 | 124 | 0.050 |
Why?
|
| Cilia | 2 | 1998 | 492 | 0.050 |
Why?
|
| Incidence | 3 | 2013 | 21337 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 16967 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 1866 | 0.050 |
Why?
|
| Back Pain | 1 | 2006 | 545 | 0.050 |
Why?
|
| Sperm Motility | 2 | 1995 | 266 | 0.050 |
Why?
|
| Kidney Diseases | 2 | 1990 | 2090 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2007 | 802 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2017 | 1813 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2002 | 153 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1988 | 943 | 0.050 |
Why?
|
| Recovery of Function | 3 | 2017 | 2978 | 0.050 |
Why?
|
| Obesity, Abdominal | 2 | 2017 | 373 | 0.050 |
Why?
|
| Psychometrics | 1 | 2011 | 3060 | 0.050 |
Why?
|
| Self Concept | 1 | 2007 | 1046 | 0.050 |
Why?
|
| Demography | 1 | 2006 | 1643 | 0.050 |
Why?
|
| Cell Division | 1 | 2008 | 4457 | 0.050 |
Why?
|
| Hemorrhage | 2 | 1990 | 3418 | 0.050 |
Why?
|
| Heat Stress Disorders | 1 | 2002 | 80 | 0.050 |
Why?
|
| International Cooperation | 2 | 2017 | 1421 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2689 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2003 | 1848 | 0.040 |
Why?
|
| Adolescent | 3 | 2019 | 88234 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 2 | 1979 | 120 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12447 | 0.040 |
Why?
|
| Logistic Models | 1 | 2014 | 13245 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 42188 | 0.040 |
Why?
|
| Vasovasostomy | 1 | 1998 | 6 | 0.040 |
Why?
|
| HIV-1 | 1 | 1996 | 6858 | 0.040 |
Why?
|
| Trichomonas Infections | 1 | 1998 | 41 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2009 | 2768 | 0.040 |
Why?
|
| Rhinitis | 1 | 2006 | 747 | 0.040 |
Why?
|
| Trichomonas vaginalis | 1 | 1998 | 70 | 0.040 |
Why?
|
| Headache | 1 | 2006 | 1255 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 1997 | 25 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14648 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4611 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2223 | 0.040 |
Why?
|
| Mice | 6 | 2002 | 81368 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 206 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1997 | 249 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1998 | 696 | 0.030 |
Why?
|
| Tuberculosis, Male Genital | 1 | 1996 | 6 | 0.030 |
Why?
|
| Prognosis | 2 | 2007 | 29600 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36402 | 0.030 |
Why?
|
| Neoplasms | 1 | 2005 | 22131 | 0.030 |
Why?
|
| Ejaculation | 1 | 2015 | 59 | 0.030 |
Why?
|
| Female | 12 | 2021 | 392148 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2009 | 8618 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2003 | 4010 | 0.030 |
Why?
|
| Algorithms | 3 | 2011 | 14018 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8516 | 0.030 |
Why?
|
| Urinary Sphincter, Artificial | 1 | 1995 | 23 | 0.030 |
Why?
|
| Sperm Count | 1 | 1995 | 229 | 0.030 |
Why?
|
| Hernia | 1 | 1995 | 68 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2003 | 1323 | 0.030 |
Why?
|
| Leydig Cell Tumor | 1 | 1994 | 29 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 531 | 0.030 |
Why?
|
| Cells | 1 | 1995 | 164 | 0.030 |
Why?
|
| Mycobacterium | 1 | 1996 | 251 | 0.030 |
Why?
|
| Rats | 2 | 2003 | 23717 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1997 | 487 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2015 | 54360 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1995 | 673 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 1992 | 76 | 0.030 |
Why?
|
| Body Weight | 1 | 2003 | 4614 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2006 | 3533 | 0.030 |
Why?
|
| Adenoma | 1 | 2003 | 2159 | 0.030 |
Why?
|
| Lipids | 1 | 2004 | 3332 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 1992 | 150 | 0.030 |
Why?
|
| Semen | 1 | 1995 | 347 | 0.030 |
Why?
|
| Lymphokines | 1 | 1995 | 925 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2002 | 22115 | 0.020 |
Why?
|
| Burkitt Lymphoma | 1 | 1994 | 335 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 1992 | 222 | 0.020 |
Why?
|
| Papaverine | 1 | 1991 | 45 | 0.020 |
Why?
|
| Yohimbine | 1 | 1991 | 62 | 0.020 |
Why?
|
| Urethra | 1 | 1993 | 403 | 0.020 |
Why?
|
| Women's Health | 1 | 2021 | 2065 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 1997 | 1970 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 2015 | 645 | 0.020 |
Why?
|
| Endothelium | 1 | 1993 | 764 | 0.020 |
Why?
|
| Sexology | 1 | 2010 | 1 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 1992 | 457 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1993 | 659 | 0.020 |
Why?
|
| Reperfusion | 1 | 1991 | 271 | 0.020 |
Why?
|
| Thymus Gland | 1 | 1995 | 1243 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1992 | 2185 | 0.020 |
Why?
|
| Lithotripsy, Laser | 1 | 1990 | 44 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1738 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 1784 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1997 | 5034 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1437 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 1990 | 193 | 0.020 |
Why?
|
| Abdomen | 1 | 1995 | 1128 | 0.020 |
Why?
|
| Spleen | 1 | 1995 | 2286 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20074 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1999 | 2515 | 0.020 |
Why?
|
| Age of Onset | 1 | 2015 | 3302 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1779 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1623 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 3608 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 982 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1997 | 11069 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 23416 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2002 | 14389 | 0.020 |
Why?
|
| Mortality | 1 | 2017 | 2899 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 29868 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 26049 | 0.020 |
Why?
|
| Equipment Design | 1 | 1993 | 3501 | 0.020 |
Why?
|
| Safety | 1 | 2010 | 1149 | 0.020 |
Why?
|
| Radiography | 1 | 1996 | 6961 | 0.020 |
Why?
|
| Coitus | 1 | 2005 | 132 | 0.020 |
Why?
|
| Nephrectomy | 1 | 1990 | 937 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.010 |
Why?
|
| Gene Expression | 1 | 1997 | 7568 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1994 | 1405 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8166 | 0.010 |
Why?
|
| Focus Groups | 1 | 2009 | 1409 | 0.010 |
Why?
|
| DNA | 1 | 1997 | 7196 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2015 | 2495 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1990 | 1092 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 942 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2009 | 2697 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2019 | 12943 | 0.010 |
Why?
|
| Endoscopy | 1 | 1990 | 1851 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7960 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2015 | 4785 | 0.010 |
Why?
|
| Castration | 1 | 1979 | 151 | 0.010 |
Why?
|
| Kidney | 1 | 1995 | 7045 | 0.010 |
Why?
|
| Liver | 1 | 1995 | 7512 | 0.010 |
Why?
|
| Hypothalamus | 2 | 1979 | 999 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22148 | 0.010 |
Why?
|
| Decision Making | 1 | 2011 | 3918 | 0.010 |
Why?
|
| Kidney Neoplasms | 2 | 1990 | 4250 | 0.010 |
Why?
|
| Silicone Elastomers | 1 | 1995 | 78 | 0.010 |
Why?
|
| Aggression | 1 | 1979 | 750 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1995 | 748 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5835 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1990 | 20556 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 1995 | 487 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 11736 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1995 | 3492 | 0.000 |
Why?
|
| Angiography | 1 | 1989 | 1596 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 12758 | 0.000 |
Why?
|
| Diencephalon | 1 | 1979 | 54 | 0.000 |
Why?
|
| Septum Pellucidum | 1 | 1979 | 54 | 0.000 |
Why?
|
| Telencephalon | 1 | 1979 | 141 | 0.000 |
Why?
|
| Mesencephalon | 1 | 1979 | 333 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 11874 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1989 | 5964 | 0.000 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1979 | 702 | 0.000 |
Why?
|
| Brain Stem | 1 | 1979 | 858 | 0.000 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1989 | 3164 | 0.000 |
Why?
|
| Corpus Striatum | 1 | 1979 | 1235 | 0.000 |
Why?
|
| Brain | 1 | 1979 | 27101 | 0.000 |
Why?
|
| Amygdala | 1 | 1979 | 1353 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1979 | 6634 | 0.000 |
Why?
|